Return Home

IA2030 Scorecard

 — 

Global

  • Type to select a Country

SP 6: Supply & Sustainability
6.3

Immunization expenditure from domestic resources

What Does this Indicator Measure?

This indicator measures the proportion of low- and middle-income countries whose share of national vaccine expenditure that is funded by domestic government resources increased or remained stable. It signals whether countries are transitioning away from aid in spending on vaccines by calculating both the change in overall expenditure level on vaccines as well as the change in share of total vaccine expenditure paid from domestic government resources as opposed to external aid.

How Will Progress be Measured?

Each year, an increasing proportion of low- and middle-income countries should observe progress by increasing or remaining stable their share of national vaccine expenditure funded by domestic government resources. Countries should aim to secure more domestic government resources to procure vaccines and the proportion of funds for vaccines coming from domestic budgets should increase over the course of the decade.

Proportion of countries whose share of national immunization schedule vaccine expenditure funded by domestic government resources increased or remained stable—Global

= 
Declining share and declining expenditure level
= 
Declining share but increasing/stable expenditure level
= 
Stable share
= 
Increasing share but declining expenditure level
= 
Increasing share and increasing/stable expenditure level

Summary Table

2018-20192019-20202020-2021
Declining share and declining expenditure level27.0%18.9%18.9%
Declining share but increasing/stable expenditure level13.5%5.4%18.9%
Stable share16.2%16.2%13.5%
Increasing share but declining expenditure level8.1%13.5%10.8%
Increasing share and increasing/stable expenditure level35.1%45.9%37.8%
Definition: Proportion of countries* whose share of current expenditure on vaccines (in the national immunization schedule) financed with domestic government funds increased since pre-2020 level. (*Note that data were only available for 37 low- and middle-income countries for the current analysis)
Measurement approach: To monitor growth, proposed methodology is to compare shares of Yt with Yt-1. The total value of vaccines used for the provision of immunization. All the materials and services are to be fully consumed during the production activity period. Domestic public resources spent on all vaccines used in conformity with the national immunization programme, including routine doses of vaccines, and following each country’s vaccination schedule. Includes the international market price, as well as transport and handling expenditures. Vaccines used in Child Health Days are included in routine vaccine expenditures, but expenditures related to doses of vaccine given through supplemental immunization activities (SIAs) are excluded.
Calculation: The share is calculated from domestic government spending on vaccines as a % of total expenditure on routine immunization vaccines. The trend calculation will be defined subsequently, leveraging methodologies used for WHO GHED and GHER (Global Health Expenditure Report).
Data source: WHO/UNICEF Joint Reporting Form on Immunization (JRF)

The IA2030 Scorecard visualizes the monitoring and evaluation indicators of the IA2030 Framework for Action endorsed in 2020 by the World Health Assembly, with the support of countries and partners. The scorecard is a collaborative effort led by MOMENTUM Country and Global Leadership working in partnership with the IA2030 Working Groups on Monitoring & Evaluation and Communications & Advocacy, with oversight from the IA2030 Secretariat and Coordinating Committee. Share feedback here.

This resource is freely available for use per the Creative Commons license: Attribution 4.0 International.


Citation: Immunization Agenda (IA2030) Scorecard. scorecard.immunizationagenda2030.org.
US AID and Momemtum logos